V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20192641 | 20124021 | 1.72 | 73.8 | null | 2019-11-30 | 2019-12-13 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100347947 |
| 20192643 | 20124022 | 1.77 | 80.9 | null | 2018-11-05 | 2018-11-13 | Cetuximab + FOLFIRI cycle 2 onwards | 01 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100780294 |
| 20192644 | 20124023 | 1.71 | 80.3 | Palliative (P) | 2018-10-08 | 2019-12-06 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100260679 |
| 20192649 | 20124024 | 1.7 | 65 | null | 2019-07-04 | 2019-07-04 | Gemcitabine + Capecitabine | 02 | null | CAPECITABINE + GEMCITABINE | 100809156 |
| 20192650 | 20124025 | 1.91 | 68.9 | Palliative (P) | 2019-08-19 | 2019-09-02 | Docetaxel | 02 | N | DOCETAXEL | 100987323 |
| 20192657 | 20124026 | 1.97 | 87.4 | Palliative (P) | 2017-04-08 | 2017-04-10 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100459037 |
| 20192660 | 20124027 | 0 | 65.4 | Palliative (P) | 2017-11-30 | 2017-11-30 | Docetaxel | 02 | N | DOCETAXEL | 101673297 |
| 20192677 | 20124028 | 1.94 | 63.85 | Palliative (P) | 2018-05-04 | 2018-05-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101724868 |
| 20192682 | 20124029 | 1.59 | 73 | Palliative (P) | 2018-10-07 | 2018-12-14 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100750529 |
| 20192690 | 20124030 | 1.55 | 48.25 | Palliative (P) | 2017-09-10 | 2017-10-15 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100803489 |
| 20192693 | 20124031 | 1.69 | 103 | Palliative (P) | 2017-01-18 | 2017-02-09 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101324990 |
| 20192698 | 20124032 | 1.69 | 68 | Palliative (P) | 2018-04-10 | 2018-04-11 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100331580 |
| 20192701 | 20124033 | 1.67 | 87.4 | Palliative (P) | 2018-07-20 | 2018-07-31 | CETUXIMAB + IRINOTECAN + MDG | null | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100618700 |
| 20192703 | 20124034 | 1.67 | 72.8 | Palliative (P) | 2019-01-08 | 2019-01-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100465108 |
| 20192709 | 20124035 | 1.76 | 65 | Neo-adjuvant (N) | 2021-02-02 | 2021-11-08 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100881772 |
| 20192713 | 20124036 | 1.67 | 51.2 | null | 2016-03-23 | 2016-05-02 | Docetaxel 75mg/m2 (21 day) | 02 | null | DOCETAXEL | 100692401 |
| 20192720 | 20124037 | 1.67 | 110 | 03 | 2017-07-13 | 2017-07-18 | Docetaxel 75mg/m2 (21 day) | N | N | DOCETAXEL | 101588202 |
| 20192724 | 20124038 | 1.86 | 67.85 | Palliative (P) | 2016-10-17 | 2016-10-17 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101666804 |
| 20192727 | 20124039 | 1.81 | 59.9 | Palliative (P) | 2018-07-09 | 2018-08-12 | Cetuximab + FOLFIRI cycle1 | 02 | N | CAPECITABINE + GEMCITABINE | 100621169 |
| 20192732 | 20124040 | 1.7 | 67.9 | Palliative (P) | 2020-03-06 | 2020-03-06 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 101711961 |
| 20192733 | 20124041 | 1.86 | 103.1 | Palliative (P) | 2018-09-26 | 2018-09-26 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101460866 |
| 20192734 | 20124042 | 1.41 | 69.3 | Palliative (P) | 2019-11-04 | 2019-11-04 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100593751 |
| 20192738 | 20124043 | 1.9 | 66.35 | Palliative (P) | 2018-12-23 | 2018-12-23 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100466251 |
| 20192742 | 20124044 | 1.74 | 83.7 | null | 2017-12-28 | 2018-02-05 | Docetaxel | N | null | DOCETAXEL | 101745228 |
| 20192746 | 20124045 | 1.7 | 79.2 | null | 2017-08-05 | 2017-08-05 | Gemcitabine + Capecitabine | N | null | CAPECITABINE + GEMCITABINE | 100419409 |
| 20192748 | 20124046 | 1.88 | 75.2 | null | 2018-12-12 | 2019-01-01 | Docetaxel | 02 | null | DOCETAXEL | 101296637 |
| 20192753 | 20124047 | 1.55 | 63 | Palliative (P) | 2019-10-01 | 2019-10-11 | Docetaxel | 02 | N | DOCETAXEL | 101712611 |
| 20192754 | 20124048 | 1.69 | 93.4 | null | 2019-08-20 | 2019-08-26 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100204322 |
| 20192755 | 20124049 | 1.52 | 71.8 | Palliative (P) | 2020-07-21 | 2020-07-21 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101472999 |
| 20192759 | 20124050 | 1.7 | 51.1 | Palliative (P) | 2020-01-21 | 2020-03-13 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100852409 |
| 20192760 | 20124051 | null | 83 | Palliative (P) | 2018-08-18 | 2018-08-18 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100396256 |
| 20192769 | 20124052 | 1.49 | 82.35 | Palliative (P) | 2018-09-30 | 2018-12-23 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100849002 |
| 20192770 | 20124053 | 1.76 | 61.9 | null | 2016-11-27 | 2017-05-09 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | DOCETAXEL | 101115625 |
| 20192775 | 20124054 | 1.69 | 57.2 | null | 2019-04-28 | 2019-07-14 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CAPECITABINE + GEMCITABINE | 100876374 |
| 20192777 | 20124055 | 1.67 | 103 | Palliative (P) | 2020-10-18 | 2020-10-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100942088 |
| 20192779 | 20124056 | 1.65 | 45 | Palliative (P) | 2019-05-21 | 2019-05-21 | Docetaxel 100mg/m2 (21 day) | N | N | DOCETAXEL | 101497174 |
| 20192780 | 20124057 | 1.6 | 92.6 | Adjuvant (A) | 2019-11-28 | 2019-12-02 | Docetaxel | 02 | N | DOCETAXEL | 100210527 |
| 20192788 | 20124058 | 1.81 | 54.3 | null | 2017-12-11 | 2018-10-31 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | DOCETAXEL | 101371702 |
| 20192790 | 20124059 | 1.76 | 81.4 | Palliative (P) | 2015-12-29 | 2015-12-29 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100448119 |
| 20192795 | 20124060 | null | 87.6 | Palliative (P) | 2018-08-30 | 2018-08-30 | Docetaxel 100mg/m2 (21 day) | 02 | N | DOCETAXEL | 101630700 |
| 20192797 | 20124061 | null | 71.4 | Palliative (P) | 2018-07-21 | 2018-07-21 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100755748 |
| 20192801 | 20124062 | 1.55 | 82 | Palliative (P) | 2018-11-19 | 2018-11-19 | CAPECITABINE + GEMCITABINE | 02 | N | CAPECITABINE + GEMCITABINE | 100504601 |
| 20192803 | 20124063 | 1.81 | 60 | Palliative (P) | 2017-10-25 | 2017-10-25 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100809753 |
| 20192806 | 20124064 | 1.6 | 90.4 | Palliative (P) | 2020-07-04 | 2020-07-15 | CETUXIMAB + IRINOTECAN + MDG | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 101120314 |
| 20192809 | 20124065 | 0 | 81.1 | Palliative (P) | 2018-10-16 | 2018-10-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | DOCETAXEL | 101165180 |
| 20192811 | 20124066 | 1.7 | 92.8 | null | 2018-12-24 | 2019-02-08 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | CETUXIMAB + FLUOROURACIL + IRINOTECAN | 100739022 |
| 20192814 | 20124067 | 1.83 | 60.3 | Palliative (P) | 2019-04-04 | 2019-04-21 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | N | CAPECITABINE + GEMCITABINE | 101150958 |
| 20192817 | 20124068 | 1.95 | 67.3 | Palliative (P) | 2020-03-05 | 2020-03-19 | Gemcitabine + Capecitabine | 02 | N | CAPECITABINE + GEMCITABINE | 100013216 |
| 20192818 | 20124069 | 1.69 | 85 | Palliative (P) | 2019-08-11 | 2019-08-23 | Docetaxel | 02 | N | DOCETAXEL | 100056563 |
| 20192822 | 20124070 | 1.74 | 69.7 | Palliative (P) | 2019-05-08 | 2019-06-30 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 101439973 |